普通外科

订阅

MedSci主页 / 所有栏目 / 普通外科

Br J Surg：CSAL治疗腿部淋巴水肿

2016-11-09 MedSci MedSci原创

CSAL淋巴水肿抽脂术
关注

腿部的晚期淋巴水肿的治疗是具有挑战性的，尤其是当保守治疗失败，受影响和不受影响腿之间的体积差异变得更大时。四周负压抽脂术(CSAL)已被描述为终末期淋巴水肿腿的治疗选择。在这里，分析CSAL治疗终末期原发性和继发性淋巴水肿腿的长期结果。这是一项关于CSAL治疗单侧慢性不可逆的淋巴水肿的描述性研究。术后恢复压迫疗法。手术前测量腿体积，并在术后1、6、12和24个月后测量腿体积。47例原发性淋巴水肿患

腿部的晚期淋巴水肿的治疗是具有挑战性的，尤其是当保守治疗失败，受影响和不受影响腿之间的体积差异变得更大时。

四周负压抽脂术(CSAL)已被描述为终末期淋巴水肿腿的治疗选择。在这里，分析CSAL治疗终末期原发性和继发性淋巴水肿腿的长期结果。

这是一项关于CSAL治疗单侧慢性不可逆的淋巴水肿的描述性研究。术后恢复压迫疗法。手术前测量腿体积，并在术后1、6、12和24个月后测量腿体积。

47例原发性淋巴水肿患者，术前受影响和不受影响腿之间的体积差异中位数为3686 (IQR 2851-5121) ml。手术两年后，这个量差减少到761 ml，下降幅度为79个百分点。

41例继发性淋巴水肿患者，术前受影响和不受影响腿之间的体积差异中位数为3320 (IQR. 2533-4783) ml。手术两年后，这个量差减少到-38 ml，下降幅度为101个百分点。
 
术前容量差异和性别显着影响术后2年的最终结果。结果与体重指数或患者的其他特点不相关。

CSAL是治疗腿部原发性和继发性淋巴水肿的有效方法。

原始出处：

Lamprou DA1, Voesten HG2, Damstra RJ3, Wikkeling OR2.Circumferential suction-assisted lipectomy in the treatment of primary and secondary end-stage lymphoedema of the leg.Br J Surg. 2016 Nov 3. doi: 10.1002/bjs.10325. [Epub ahead of print]


本文系梅斯医学（MedSci）原创编译整理，转载需授权！

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=211272, encodeId=d72f2112e2f5, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Thu Jun 15 23:48:54 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333347, encodeId=49b9133334e55, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64238, encryptionId=4ce26423802, topicName=水肿)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKCRibWHQArPHdSkqP90U1HwwqlGeU7BUgzY240D3v2ibBDJ09ybkGkwOjxz7qRmngZaGlK1taX6hfA/132, createdBy=2e772500094, createdName=小华子, createdTime=Fri Nov 11 06:54:00 CST 2016, time=2016-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366591, encodeId=3f0f136659166, content=<a href='/topic/show?id=66b76595ebf' target=_blank style='color:#2F92EE;'>#淋巴水肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65957, encryptionId=66b76595ebf, topicName=淋巴水肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ce4238, createdName=dangious, createdTime=Fri Nov 11 06:54:00 CST 2016, time=2016-11-11, status=1, ipAttribution=)]
    2017-06-15 luominglian113

    学习了，谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=211272, encodeId=d72f2112e2f5, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Thu Jun 15 23:48:54 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333347, encodeId=49b9133334e55, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64238, encryptionId=4ce26423802, topicName=水肿)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKCRibWHQArPHdSkqP90U1HwwqlGeU7BUgzY240D3v2ibBDJ09ybkGkwOjxz7qRmngZaGlK1taX6hfA/132, createdBy=2e772500094, createdName=小华子, createdTime=Fri Nov 11 06:54:00 CST 2016, time=2016-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366591, encodeId=3f0f136659166, content=<a href='/topic/show?id=66b76595ebf' target=_blank style='color:#2F92EE;'>#淋巴水肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65957, encryptionId=66b76595ebf, topicName=淋巴水肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ce4238, createdName=dangious, createdTime=Fri Nov 11 06:54:00 CST 2016, time=2016-11-11, status=1, ipAttribution=)]
    2016-11-11 小华子

    #水肿#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=211272, encodeId=d72f2112e2f5, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Thu Jun 15 23:48:54 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333347, encodeId=49b9133334e55, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64238, encryptionId=4ce26423802, topicName=水肿)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKCRibWHQArPHdSkqP90U1HwwqlGeU7BUgzY240D3v2ibBDJ09ybkGkwOjxz7qRmngZaGlK1taX6hfA/132, createdBy=2e772500094, createdName=小华子, createdTime=Fri Nov 11 06:54:00 CST 2016, time=2016-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366591, encodeId=3f0f136659166, content=<a href='/topic/show?id=66b76595ebf' target=_blank style='color:#2F92EE;'>#淋巴水肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65957, encryptionId=66b76595ebf, topicName=淋巴水肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ce4238, createdName=dangious, createdTime=Fri Nov 11 06:54:00 CST 2016, time=2016-11-11, status=1, ipAttribution=)]
    2016-11-11 dangious

    #淋巴水肿#

    0